Latest filing published 03 Jun 2011 for Talecris Biotherapeutics Holdings Corp..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Ruedi E. Waeger has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alexion Pharmaceuticals Inc and Talecris Biotherapeutics Holdings Corp. Over a trading history stretching from 9 January 2006 to 1 June 2011, the count stands at 12 filings.
The open-market side counts 2 purchases for €128k alongside 1 sale for €1.2M. Netting one side against the other leaves €1.0M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants and 3 option exercises.
The record was last updated on 3 June 2011 with a transaction in Talecris Biotherapeutics Holdings Corp. The last purchase on record was published on 5 May 2010, which is 6,016 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations